1. Home
  2. GMM vs VNRX Comparison

GMM vs VNRX Comparison

Compare GMM & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Mofy Metaverse Limited

GMM

Global Mofy Metaverse Limited

N/A

Current Price

$1.21

Market Cap

76.8M

Sector

N/A

ML Signal

N/A

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.20

Market Cap

31.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GMM
VNRX
Founded
2017
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.8M
31.9M
IPO Year
2022
2012

Fundamental Metrics

Financial Performance
Metric
GMM
VNRX
Price
$1.21
$0.20
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$2.50
AVG Volume (30 Days)
165.7K
1.9M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
N/A
N/A
Revenue
N/A
$1,233,511.00
Revenue This Year
N/A
$60.84
Revenue Next Year
N/A
$404.89
P/E Ratio
N/A
N/A
Revenue Growth
N/A
59.10
52 Week Low
$0.94
$0.17
52 Week High
$4.75
$0.94

Technical Indicators

Market Signals
Indicator
GMM
VNRX
Relative Strength Index (RSI) 48.08 38.64
Support Level $1.04 $0.17
Resistance Level $3.18 $0.33
Average True Range (ATR) 0.15 0.02
MACD 0.00 0.00
Stochastic Oscillator 20.99 33.37

Price Performance

Historical Comparison
GMM
VNRX

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital asset development for the metaverse industry. The Company leverages its proprietary Mofy Lab technology platform, which integrates three-dimensional (3D) reconstruction technology and artificial intelligence (AI) interactive technology, to create high-definition virtual versions of physical world objects, including humans, animals, and scenes. It provides comprehensive technology solutions to support virtual content production for use across movies, television series, animation, advertising, and gaming. The Company operates through Virtual Technology Services, which generates the majority of revenue, and Digital Asset Development and others.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: